BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7493812)

  • 1. High-energy gamma rays in Hiroshima and Nagasaki: implications for risk and WR.
    Straume T
    Health Phys; 1995 Dec; 69(6):954-6. PubMed ID: 7493812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DS02 fluence spectra for neutrons and gamma rays at Hiroshima and Nagasaki with fluence-to-kerma coefficients and transmission factors for sample measurements.
    Egbert SD; Kerr GD; Cullings HM
    Radiat Environ Biophys; 2007 Nov; 46(4):311-25. PubMed ID: 17643260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrons confirmed in Nagasaki and at the Army Pulsed Radiation Facility: implications for Hiroshima.
    Straume T; Harris LJ; Marchetti AA; Egbert SD
    Radiat Res; 1994 May; 138(2):193-200. PubMed ID: 8183989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerator mass spectrometry of 63Ni at the Munich Tandem Laboratory for estimating fast neutron fluences from the Hiroshima atomic bomb.
    Rühm W; Knie K; Rugel G; Marchetti AA; Faestermann T; Wallner C; McAninch JE; Straume T; Korschinek G
    Health Phys; 2000 Oct; 79(4):358-64. PubMed ID: 11007457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
    Kellerer AM; Nekolla E
    Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory.
    Rühm W; Carroll KL; Egbert SD; Faestermann T; Knie K; Korschinek G; Martinelli RE; Marchetti AA; McAninch JE; Rugel G; Straume T; Wallner A; Wallner C; Fujita S; Hasai H; Hoshi M; Shizuma K
    Radiat Environ Biophys; 2007 Nov; 46(4):327-38. PubMed ID: 17828415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of fast neutrons in Hiroshima by use of (39)Ar.
    Nolte E; Rühm W; Loosli HH; Tolstikhin I; Kato K; Huber TC; Egbert SD
    Radiat Environ Biophys; 2006 Mar; 44(4):261-71. PubMed ID: 16429279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of neutrons in Hiroshima. Implications for the risk estimates.
    Kellerer AM
    C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-ray exposure from neutron-induced radionuclides in soil in Hiroshima and Nagasaki based on DS02 calculations.
    Imanaka T; Endo S; Tanaka K; Shizuma K
    Radiat Environ Biophys; 2008 Jul; 47(3):331-6. PubMed ID: 18368418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of absorbed dose in thyroids and gonads of survivors in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Nishimura A
    Acta Radiol Ther Phys Biol; 1974 Oct; 13(5):411-24. PubMed ID: 4462365
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 19. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-ray thermoluminescence measurements: a record of fallout deposition in Hiroshima?
    Egbert SD; Kerr GD
    Radiat Environ Biophys; 2012 May; 51(2):113-31. PubMed ID: 22421931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.